# MEK in cancer and cancer therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mek-in-cancer-and-cancer-therapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cindy Neuzillet,Annemilaï Tijeras‐Raballand,Louis de Mestier,Jérôme Cros,Sandrine Faivre,Éric Raymond |
| Citations | 266 |
| DOI | 10.1016/j.pharmthera.2013.10.001 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2065455574 |
| PMID | 24121058 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jérôme Cros](https://scholariq.org/researchers/jerome-cros/)

## Paper journal

- [Pharmacology & Therapeutics](https://scholariq.org/journals/pharmacology-and-therapeutics/)

## Paper primary topic

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Paper topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.